ATTO Director Colin Walsh Buys $8.5M in Cluster Buy
A new Form 4 filing shows Colin Walsh, a director at Attovia Therapeutics, Inc. (ATTO), purchased 500,000 shares of company stock on the open market on August 6, 2026. The purchase price was $17.00 per share, bringing the total outlay to $8,500,000.00. Following the transaction, Walsh’s indirect holdings — held via a trust or entity … Read more